Q2 FY27 profit up 34%; bed capacity targeted at 15,070
ASTERDM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The revised presentation corrects the workforce figure to more than 38,000; results are unchanged. Q2 revenue was INR 2,829 crore, up 19%, operating EBITDA rose 25% to INR 678 crore and margin reached 24.0%. Normalised profit rose 34% to INR 281 crore. H1 revenue rose 20% to INR 5,429 crore. Q2 merger synergies were INR 16.6 crore. Management projects 4,230 bed additions, taking capacity from 10,840 to 15,070 across FY27 to FY30 and beyond.
Strong growth and margin expansion support the outlook. A larger bed network adds long-term potential, but execution and capital needs remain risks.